Tesofensine (Tesofesin) 500 mcg 30 caps

What is Tesofensine ?

Tesofensine (tesofensine) is a synthetic, small-molecule pharmacological compound that has been the subject of clinical trials as a potential agent for modulating body weight and energy metabolism. The substance was originally developed in the context of neurodegenerative diseases, but over the course of the study, significant effects on the regulation of appetite and energy balance were observed.

In the scientific literature, tesofensine is classified as a triple reuptake inhibitor of monoamines (dopamine, norepinephrine and serotonin), making it an interesting subject for research into the central regulation of appetite.

Also check out O304 100mg/30caps

The mechanism of action of Tesofensine as described in studies

Tesofensine exhibits a multilevel central effect, focusing on the modulation of brain structures responsible for the regulation of appetite and eating behaviour. Scientific publications indicate that its effect is not limited to reducing the sensation of hunger, but also includes a reduction in the hedonic urge to eat and an intensification of satiety signals. This mechanism has been linked to modulation of monoaminergic systems regulating appetite and food motivation (Source: PMC11042726).

Based on data from clinical and review studies, the following mechanisms of action observed in studies stand out:

1. Appetite reduction - by increasing the availability of central neurotransmitters involved in appetite control, leading to a reduction in spontaneous energy intake.
2. Modulation of hedonic eating behaviour - reduction of eating motivated by reward rather than actual energy requirements.
3. Effects on energy balance - the observed weight reduction is mainly due to reduced calorie intake, with no clear evidence of direct stimulation of peripheral metabolism.
4. Changes in body composition - no clear selective loss of lean body mass has been demonstrated in clinical trials, but the long-term effects on body composition require further analysis.

Tesofensine and general observations in scientific studies

Based on clinical data and review analyses, a statistically significant reduction in body weight was reported compared to placebo. In a randomised, double-blind phase II clinical trial of 24 weeks duration, it was shown that:

• Participants receiving tesofensine 0.5 mg/day achieved an average weight reduction of approximately 11.2 kg,
• in the placebo group, the average weight reduction was approximately 2.2 kg over the same observation period,
• difference between the groups was statistically significant, confirming a clear pharmacodynamic effect of the compound.

In addition, the study authors indicated that the observed weight loss was mainly a consequence of a reduction in energy intake, resulting from central appetite modulation, rather than an increase in basal metabolism. The weight loss effect showed a dose-dependent effect, with a concomitant increase in the frequency of adverse effects at higher exposure levels.

Additional scientific source - key findings from clinical trials

Astrup A. et al, The Lancet, 2008
Tesofensine, a novel triple monoamine reuptake inhibitor, induces weight loss in obese subjects

In a landmark randomised clinical trial published in the prestigious journal The Lancet the authors showed that tesofensine led to significantly greater weight reduction compared to many of the drug therapies evaluated for the treatment of obesity at the time. The observed effect was attributed to a central mechanism of action involving simultaneous modulation of anorectic systems and neuronal reward pathways associated with eating behaviour.

The authors of the publication unequivocally stressed that, despite its high short-term efficacy, the central nature of tesofensine's effects requires further long-term clinical studies, particularly in the context of safety and tolerability. This work was one of the key references that established tesofensine as a model compound for research into the neurobiological regulation of appetite and body weight.

Safety and study protocols – clinical data

Based on published clinical studies, tesofensine was assessed as a compound with an acceptable tolerability profile in short-term clinical trials, with the frequency and severity of adverse effects showing a dose-dependent relationship. In the studies, mainly central symptoms such as agitation or sleep disturbances were reported, which is consistent with the central mechanism of action of the compound.

A randomised, double-blind phase II clinical trial showed that higher doses of tesofensine led to a greater reduction in body weight, with a concomitant increase in the incidence of side effects. A dose of 0.5 mg/day was associated with an average weight reduction of approximately 11.2 kg over 24 weeks, compared to approximately 2.2 kg in the placebo group (Source: PMID 18950853).

Tesofensine - where to buy and availability online

If you wish to purchase tesofensine or are looking to order tesofensine online as a research compound used in laboratory analyses and scientific projects, the substance is available from specialist chemical reagent suppliers. Tesofensine is offered as a research use only material (Research Use Only).

The purchase of tesofensine online provides quick and transparent access to a compound that is the subject of research into the central mechanisms of appetite regulation and energy balance. This type of offer is aimed at laboratories, research teams and entities conducting research and development in the fields of pharmacology, neuroscience and metabolic sciences.

For those typing in phrases such as „tesofensine buy”, it is not only the availability of the product that is crucial, but also the quality and transparency of its origin.

The order process has been designed to make it as easy as possible to purchase tesofensine for research - whether the aim is to quickly obtain reference material or to compare the properties of tesofensine with other research compounds used in analyses of appetite regulation.

See also reagent SLU-PP-332 500mcg/60caps

Tesofensine - scientific summary

Tesofensine is an interesting research compound used to analyse the central mechanisms of appetite and energy balance control. Clinical data indicate high short-term weight reduction efficacy, but at the same time highlight the limitations due to the central mechanism of action and the lack of long-term safety data. In the current state of knowledge, tesofensine remains an investigational tool and not a substance approved for clinical use outside controlled scientific protocols.

Scientific sources:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61525-1/abstract

https://pmc.ncbi.nlm.nih.gov/articles/PMC11042726/

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.